225 related articles for article (PubMed ID: 24518414)
1. Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.
Saldanha SN; Kala R; Tollefsbol TO
Exp Cell Res; 2014 May; 324(1):40-53. PubMed ID: 24518414
[TBL] [Abstract][Full Text] [Related]
2. Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.
Sánchez-Tena S; Vizán P; Dudeja PK; Centelles JJ; Cascante M
Biochim Biophys Acta; 2013 Dec; 1832(12):2264-70. PubMed ID: 23994611
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
Zhang X; Min KW; Wimalasena J; Baek SJ
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
[TBL] [Abstract][Full Text] [Related]
4. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.
Moseley VR; Morris J; Knackstedt RW; Wargovich MJ
Anticancer Res; 2013 Dec; 33(12):5325-33. PubMed ID: 24324066
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea.
Du GJ; Zhang Z; Wen XD; Yu C; Calway T; Yuan CS; Wang CZ
Nutrients; 2012 Nov; 4(11):1679-91. PubMed ID: 23201840
[TBL] [Abstract][Full Text] [Related]
8. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention.
Zeng H; Hamlin SK; Safratowich BD; Cheng WH; Johnson LK
Nutr Res; 2020 Nov; 83():63-72. PubMed ID: 33017771
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
Borutinskaitė V; Virkšaitė A; Gudelytė G; Navakauskienė R
Leuk Lymphoma; 2018 Feb; 59(2):469-478. PubMed ID: 28641467
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells.
Ahmad N; Gupta S; Mukhtar H
Arch Biochem Biophys; 2000 Apr; 376(2):338-46. PubMed ID: 10775421
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway.
La X; Zhang L; Li Z; Li H; Yang Y
J Agric Food Chem; 2019 Mar; 67(9):2510-2518. PubMed ID: 30741544
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect and mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 colorectal cancer cell lines and expression of HES1 and JAG1].
Zhang CX; Wang SM; Jin HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):636-9. PubMed ID: 21866461
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate hinders human hepatoma and colon cancer sphere formation.
Wubetu GY; Shimada M; Morine Y; Ikemoto T; Ishikawa D; Iwahashi S; Yamada S; Saito Y; Arakawa Y; Imura S
J Gastroenterol Hepatol; 2016 Jan; 31(1):256-64. PubMed ID: 26241688
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
18. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
[TBL] [Abstract][Full Text] [Related]
19. Aberrant epigenetic alteration in Eca9706 cells modulated by nanoliposomal quercetin combined with butyrate mediated via epigenetic-NF-κB signaling.
Zheng NG; Wang JL; Yang SL; Wu JL
Asian Pac J Cancer Prev; 2014; 15(11):4539-43. PubMed ID: 24969881
[TBL] [Abstract][Full Text] [Related]
20. Butyrate Drives Metabolic Rewiring and Epigenetic Reprogramming in Human Colon Cancer Cells.
Wang L; Shannar AAF; Wu R; Chou P; Sarwar MS; Kuo HC; Peter RM; Wang Y; Su X; Kong AN
Mol Nutr Food Res; 2022 Jun; 66(12):e2200028. PubMed ID: 35429118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
